| CBT + M (n = 49) | M (n = 49) | χ2/t value | p value | |
---|---|---|---|---|---|
Male(%) | 27 (55.1) | 31 (63.3) | 0.676 | 0.411 | |
age [mean (SD)] | 26.8 (5.7) | 24.8 (5.6) | 1.816 | 0.072 | |
FIQ [mean (SD)] | 122.8 (9.1) | 119.5 (9.8) | 1.704 | 0.092 | |
ADHD subtype (%) | Â | Â | Â | Â | |
 | Predominantly inattentive | 31 (63.3) | 28 (57.1) | 0.383 | 0.536 |
 | Combined | 18 (36.7) | 21 (42.9) |  |  |
Year of education [mean (SD)] | 16.4 (2.4) | 15.7 (2.5) | 1.454 | 0.149 | |
Current Axis I Disorder (%) | 21 (42.9) | 23 (46.9) | 0.165 | 0.685 | |
≥1 Current Axis I Disorder (%) | 7 (14.3) | 8 (16.3) | 0.079 | 0.779 | |
Affective Disorder (%) | 11 (22.5) | 14 (28.6) | 0.483 | 0.487 | |
 | Bipolar Disorder | 4 (8.16) | 4 (8.16) | 0.000 | 1.000 |
 | Major Depressive Disorder (%) | 6 (12.24) | 9 (18.37) | 0.708 | 0.400 |
 | Dysthymia (%) | 1 (2.04) | 2 (4.08) | 0.344 | 1.000 |
Anxiety Disorder (%) | 13 (26.5) | 10 (20.4) | 0.511 | 0.475 | |
Comorbid Axis I disorders in remission (%) | 4 (8.2) | 7 (14.3) | 0.922 | 0.337 | |
 | Affective Disorder (%) | 4 (8.2) | 6 (12.2) | 0.445 | 0.505 |
 | Anxiety Disorder (%) | 0 (0.0) | 1 (6.7) | 1.010 | 1.000 |
Current comorbid Axis II disorders (%) | 27 (55.1) | 26 (53.1) | 0.041 | 0.839 | |
≥1 Axis II Disorder (%) | 9 (18.4) | 11 (22.5) | 0.251 | 0.616 | |
 | Cluster A (%) | 8 (16.3) | 8 (16.3) | 0.000 | 1.000 |
 | Cluster B (%) | 4 (8.2) | 6 (12.2) | 0.445 | 0.505 |
 | Cluster C (%) | 22 (44.9) | 19 (38.8) | 0.633 | 0.426 |
 | Other (%) | 9 (18.8) | 15 (30.6) | 1.986 | 0.159 |
Medication | Â | Â | Â | Â | |
 | Methylphenidate (Concerta®) | 47 (95.9) | 46 (93.9) | 1.069 | 1.000 |
 | Atomoxetine (Strattera®) | 2 (4.1) | 2 (4.1) |  |  |
 | Methylphenidate+Atomoxetine | 0 (0.0) | 1 (2.0) |  |  |